Frankfurt - Delayed Quote EUR
Simply Better Brands Corp. (5SS0.F)
0.5340
+0.0180
+(3.49%)
At close: April 25 at 8:03:50 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 10.2M | 20.2M | 70.4M | 94M |
Low Estimate | 10.2M | 20.2M | 70.4M | 94M |
High Estimate | 10.2M | 20.2M | 70.4M | 94M |
Year Ago Sales | -- | 7.05M | 45.29M | 70.4M |
Sales Growth (year/est) | -- | 186.54% | 55.45% | 33.52% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
5SS0.F | -- | -- | -- | -- |
S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
AEQ.F Aequus Pharmaceuticals Inc.
0.0005
0.00%
GENIL.IS Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
121.30
+1.08%
GABA.ST Gabather AB (publ)
0.0396
-2.94%
VCBD Vitalibis, Inc.
0.0018
+28.57%
KLAR.ST Klaria Pharma Holding AB (publ.)
1.1500
-3.77%
STX.L Shield Therapeutics plc
2.3500
+3.98%
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%
CPIX Cumberland Pharmaceuticals Inc.
4.9700
+2.58%
BCRX BioCryst Pharmaceuticals, Inc.
8.39
+2.07%